Total Payments
$664.08
2024 Payments
$93.71
Companies
10
Transactions
24
Medicare Patients
1,209
Medicare Billing
$129,438
Payment Breakdown by Category
Education$338.36 (51.0%)
Food & Beverage$325.72 (49.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $338.36 | 11 | 51.0% |
| Food and Beverage | $325.72 | 13 | 49.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $129.97 | 3 | $0 (2024) |
| Organogenesis Inc. | $112.82 | 4 | $0 (2019) |
| Janssen Products, LP | $99.00 | 1 | $0 (2022) |
| Insmed, Inc. | $97.44 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $85.94 | 4 | $0 (2023) |
| ViiV Healthcare Company | $79.63 | 1 | $0 (2022) |
| Smith & Nephew, Inc. | $28.37 | 2 | $0 (2018) |
| Gilead Sciences, Inc. | $14.74 | 1 | $0 (2018) |
| Melinta Therapeutics, LLC | $11.95 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93.71 | 4 | Insmed, Inc. ($48.72) |
| 2023 | $146.74 | 6 | Janssen Biotech, Inc. ($53.03) |
| 2022 | $236.43 | 5 | Janssen Products, LP ($99.00) |
| 2021 | $11.95 | 1 | Melinta Therapeutics, LLC ($11.95) |
| 2019 | $122.49 | 3 | Organogenesis Inc. ($103.17) |
| 2018 | $47.16 | 4 | Smith & Nephew, Inc. ($28.37) |
| 2017 | $5.60 | 1 | Organogenesis Inc. ($5.60) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $44.99 | General |
| 08/29/2024 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 02/05/2024 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 10/06/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 09/27/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $44.99 | General |
| 06/23/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 05/18/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 04/12/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $36.33 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/09/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/08/2022 | Advanced Oxygen Therapy Inc. | Topical wound oxygen (Device) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: Topical oxygen chamber for extremities | ||||||
| 09/21/2022 | Janssen Products, LP | SYMTUZA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/14/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $79.63 | General |
| Category: HIV | ||||||
| 05/23/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 04/20/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $39.99 | General |
| 10/05/2021 | Melinta Therapeutics, LLC | Vabomere (Drug) | Education | In-kind items and services | $11.95 | General |
| Category: ANTIBIOTICS | ||||||
| 08/20/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 04/09/2019 | Organogenesis Inc. | PuraPly AM (Medical Supply) | Food and Beverage | Cash or cash equivalent | $98.02 | General |
| Category: Wound Care | ||||||
| 04/09/2019 | Organogenesis Inc. | Apligraf (Device) | Food and Beverage | Cash or cash equivalent | $5.15 | General |
| Category: Wound Care | ||||||
| 08/15/2018 | Smith & Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Pharma Product | ||||||
| 08/03/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.74 | General |
| 06/27/2018 | Smith & Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Pharma Product | ||||||
| 01/31/2018 | Organogenesis Inc. | Apligraf (Biological) | Food and Beverage | Cash or cash equivalent | $4.05 | General |
| Category: Podiatry | ||||||
| 11/02/2017 | Organogenesis Inc. | Apligraf (Device) | Food and Beverage | Cash or cash equivalent | $5.60 | General |
| Category: wound | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 226 | 286 | $57,266 | $23,096 |
| 2022 | 9 | 261 | 351 | $61,092 | $26,603 |
| 2021 | 9 | 359 | 627 | $100,626 | $43,327 |
| 2020 | 10 | 363 | 575 | $87,157 | $36,411 |
Total Patients
1,209
Total Services
1,839
Medicare Billing
$129,438
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 104 | $12,125 | $6,135 | 50.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 56 | 58 | $12,828 | $5,535 | 43.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 38 | $6,390 | $3,449 | 54.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $7,203 | $2,759 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 17 | $5,238 | $1,792 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 12 | $3,697 | $1,344 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 18 | $5,217 | $1,144 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 17 | $4,567 | $938.84 | 20.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 55 | 56 | $12,386 | $5,923 | 47.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 46 | 69 | $11,603 | $5,558 | 47.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 32 | $10,477 | $4,739 | 45.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 75 | $8,744 | $4,087 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 41 | $7,211 | $2,820 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 17 | $4,019 | $1,390 | 34.6% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 12 | 32 | $3,825 | $870.70 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 17 | $2,051 | $852.24 | 41.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 12 | $776.64 | $362.95 | 46.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 94 | 162 | $18,888 | $8,977 | 47.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 55 | 59 | $13,050 | $6,337 | 48.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 38 | 39 | $12,769 | $6,020 | 47.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 71 | $12,212 | $5,457 | 44.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 49 | $8,240 | $3,931 | 47.7% |
| 97597 | Removal of tissue from wounds per session, first 20 sq cms or less | Office | 2021 | 15 | 128 | $15,299 | $3,569 | 23.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 23 | $5,334 | $2,679 | 50.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 21 | 31 | $5,332 | $2,338 | 43.9% |
About Dr. Anja Bottler, MD
Dr. Anja Bottler, MD is a Infectious Disease healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396712113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anja Bottler, MD has received a total of $664.08 in payments from pharmaceutical and medical device companies, with $93.71 received in 2024. These payments were reported across 24 transactions from 10 companies. The most common payment nature is "Education" ($338.36).
As a Medicare-enrolled provider, Bottler has provided services to 1,209 Medicare beneficiaries, totaling 1,839 services with total Medicare billing of $129,438. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Rochester, NY
- Active Since 03/01/2006
- Last Updated 04/23/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1396712113
Products in Payments
- SYMTUZA (Drug) $165.62
- PuraPly AM (Medical Supply) $98.02
- Arikayce (Drug) $97.44
- DOVATO (Drug) $79.63
- Santyl (Drug) $28.37
- Symtuza (Drug) $19.32
- Vabomere (Drug) $11.95
- Apligraf (Device) $10.75
- Topical wound oxygen (Device) $4.22
- Apligraf (Biological) $4.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Rochester
Robin Patel, M.d, M.D
Infectious Disease — Payments: $270,548
Infectious Disease $270,548
Ann Falsey, Md, MD
Infectious Disease — Payments: $191,692
Infectious Disease $191,692
Edward Walsh, Md, MD
Infectious Disease — Payments: $131,419
Infectious Disease $131,419
Emil Lesho, D.o, D.O
Infectious Disease — Payments: $65,937
Infectious Disease $65,937
Zelalem Temesgen, M.d, M.D
Infectious Disease — Payments: $56,223
Infectious Disease $56,223
Dr. Angela Branche, Md, MD
Infectious Disease — Payments: $50,957
Infectious Disease $50,957